Physiologically Tolerable Insulin Reduces Myocardial Injury and Improves Cardiac Functional Recovery in Myocardial Ischemic/Reperfused Dogs
Authors:
- 1 December 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 48 (6) , 306-313
Abstract
This study was designed to examine whether physiologically tolerable insulin, which maintains lower blood glucose, can protect the myocardium against ischemia/reperfusion (I/R) injury in a preclinical large animal model. Adult dogs were subjected to 50 minutes of myocardial ischemia (80% reduction in coronary blood flow) followed by 4 hours of reperfusion and treated with vehicle, glucose-insulin-potassium (GIK; glucose, 250 g/L; insulin, 60 U/L; potassium, 80 mmol/L), GK, or low-dose insulin (30 U/L) 10 minutes before reperfusion. Treatment with GIK exerted significant cardioprotective effects as evidenced by improved cardiac function, improved coronary blood flow, reduced infarct size, and myocardial apoptosis. In contrast, treatment with GK increased blood glucose level and aggravated myocardial I/R injury. It is interesting that treatment with insulin alone at the dose that reduced blood glucose to a clinically tolerable level exerted significant cardioprotective effects that were comparable to that seen in the GIK-treated group. This low-dose insulin had no effect on coronary blood flow after reperfusion but markedly reduced coronary reactive hyperemia and switched myocardial substrate uptake from fat to carbohydrate. Our results suggest that lower glucose supply to the ischemic myocardium at early reperfusion may create a “metabolic postconditioning” and thus reduce myocardial ischemia/reperfusion injury after prolonged reperfusion.Keywords
This publication has 31 references indexed in Scilit:
- Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: A randomized controlled trialThe Journal of Thoracic and Cardiovascular Surgery, 2006
- Vasculoprotective effect of insulin in the ischemic/reperfused canine heart: Role of Akt-stimulated NO productionCardiovascular Research, 2006
- Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty ratsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Malonyl Coenzyme A Decarboxylase Inhibition Protects the Ischemic Heart by Inhibiting Fatty Acid Oxidation and Stimulating Glucose OxidationCirculation Research, 2004
- Postconditioning attenuates myocardial ischemia–reperfusion injury by inhibiting events in the early minutes of reperfusionCardiovascular Research, 2004
- Glucose-insulin-potassium solution improves left ventricular energetics in chronic ovine diabetesThe Annals of Thoracic Surgery, 2004
- Anti-Inflammatory and Profibrinolytic Effect of Insulin in Acute ST-Segment–Elevation Myocardial InfarctionCirculation, 2004
- Nitric Oxide Mediates the Antiapoptotic Effect of Insulin in Myocardial Ischemia-ReperfusionCirculation, 2002
- Preconditioning with Ischaemia Reduces Both Myocardial Oxygen Consumption and Infarct Size in a Graded PatternJournal of Molecular and Cellular Cardiology, 1997
- Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarctionThe American Journal of Cardiology, 1962